Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis

NCT01890421 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01890421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01890421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
July 19, 2013
Completion date
August 31, 2017
Enrollment
426 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease